TWINRIX
TWINRIX
Approved
DIN Number
02230578
Drug Class
Human
Market Date
Sep 19, 1997
Company
HC
GlaxoSmithKline Inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02230578
AIG Number0265323001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
A
ATC Code
J07BC20 COMBINATIONS
Product Specifications
Dosage FormSuspension
Route of AdministrationIntramuscular
AHFS Classification80:12.00
Health Canada Classification
ACTIVE INGREDIENTS (2)
HEPATITIS A VIRUS, INACTIVATEDActive
Strength: 720 UNIT / 1 ML
Monograph: HEPATITIS A VIRUS, INACTIVATED
HEPATITIS B SURFACE ANTIGEN (RECOMBINANT)Active
Strength: 20 MCG / 1 ML
Monograph: HEPATITIS B SURFACE ANTIGEN (RECOMBINANT)